NCT05291598View on ClinicalTrials.gov

Meloxicam for Pain Management After Total Joint Arthroplasty (TJA)

PHASE3CompletedINTERVENTIONAL
Enrollment

223

Participants

Timeline

Start Date

May 1, 2022

Primary Completion Date

May 1, 2023

Study Completion Date

May 1, 2023

Conditions
Total Knee ReplacementTotal Hip Replacement
Interventions
DRUG

IV meloxicam

Participants will be administered meloxicam 30 mg IV push pre-operatively.

DRUG

Ketorolac

Participants will be treated with ketorolac 15 mg IV push intra-operatively, followed by 15 mg IV push every 6 hours scheduled for 2 doses.

Trial Locations (1)

33136

University of Miami, Miami

All Listed Sponsors
lead

University of Miami

OTHER